Similarly, in breast cancer cells, the Aurora A/Src/ERK1/2 axis determines resistance to taxol by increasing the number of cells entering S- and G2-phases, and reducing the number of apoptotic cells [97]. The gene discussed is MAPK3; the disease is breast carcinoma.